-
PDF
- Split View
-
Views
-
Cite
Cite
Nusrat J Epsi, Josh G Chenoweth, Paul W Blair, David A Lindholm, Anuradha Ganesan, Tahaniyat Lalani, Alfred Smith, Rupal M Mody, Milissa U Jones, Rhonda E Colombo, Christopher J Colombo, Christina Schofield, Evan C Ewers, Derek T Larson, Catherine M Berjohn, Ryan C Maves, Anthony C Fries, David Chang, Andrew Wyatt, Ann I Scher, Celia Byrne, Jennifer Rusiecki, David L Saunders, Jeffrey Livezey, Allison Malloy, Samantha Bazan, Carlos Maldonado, Margaret Sanchez Edwards, Katrin Mende, Mark P Simons, Robert J O’Connell, David R Tribble, Brian K Agan, Timothy H Burgess, Simon D Pollett, Stephanie A Richard, Precision symptom phenotyping identifies early clinical and proteomic predictors of distinct COVID-19 sequelae, The Journal of Infectious Diseases, 2024;, jiae318, https://doi.org/10.1093/infdis/jiae318
- Share Icon Share
Abstract
Post-COVID conditions (PCC) are difficult to characterize, diagnose, predict, and treat due to overlapping symptoms and poorly understood pathology. Identifying inflammatory profiles may improve clinical prognostication and trial endpoints.
1,988 SARS-CoV-2 positive U.S. Military Health System beneficiaries with quantitative post-COVID symptom scores were included in this analysis. Among participants who reported moderate-to-severe symptoms on surveys collected 6-months post-SARS-CoV-2 infection, principal component analysis (PCA) followed by K-means clustering identified distinct clusters of symptoms.
Three symptom-based clusters were identified: a sensory cluster (loss of smell and/or taste), a fatigue/difficulty thinking cluster, and a difficulty breathing/exercise intolerance cluster. Individuals within the sensory cluster were all outpatients during their initial COVID-19 presentation. The difficulty breathing cluster had a higher likelihood of obesity and COVID-19 hospitalization compared to those with no/mild symptoms at 6-months post-infection. Multinomial regression linked early post-infection D-dimer and IL-1RA elevation to fatigue/difficulty thinking, and elevated ICAM-1 concentrations to sensory symptoms.
We identified three distinct symptom-based PCC phenotypes with specific clinical risk factors and early post-infection inflammatory predictors. With further validation and characterization, this framework may allow more precise classification of PCC cases and potentially improve the diagnosis, prognostication, and treatment of PCC.